TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.94 Cr | ₹-0.15 Cr | ₹-0.52 Cr | ₹-1.04 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TRIDENT LIFELINE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.94 Cr |
| Mar2024 | ₹-0.15 Cr |
| Mar2023 | ₹-0.52 Cr |
| Mar2022 | ₹-1.04 Cr |
How is Deferred Tax Assets / Liabilities of TRIDENT LIFELINE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.94 Cr | Negative | |
| Mar2024 | ₹-0.15 Cr | Negative | |
| Mar2023 | ₹-0.52 Cr | Negative | |
| Mar2022 | ₹-1.04 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹354.9 Cr | -2.2% | 2.8% | 7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,468.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,810.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,170.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,300.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,575.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -2.2% |
2.8% |
7.4% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses